Catalyst Wire Dossier Catalyst Wire Dossier

Jenzyl

ridaforolimus · Merck Sharp and Dohme Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Jenzyl, covering 2012-11-30 to 2013-02-18. Get the full timeline:

Most recent: EMA Application withdrawn: Jenzyl — Merck Sharp and Dohme Ltd.

See pricing